advertisement
Zhang B 24
Showing records 1 to 24 | Display all abstracts from Zhang B104481 A proposed theoretical framework for retinal biomarkers
MacCormick IJC
Alzheimer's & dementia (Amsterdam, Netherlands) 2022; 14: e12327
104861 Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Han R
Frontiers in public health 2022; 10: 944967
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Hu X
Eye 2023; 37: 607-617
104861 Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Cheng G
Frontiers in public health 2022; 10: 944967
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Zhang B
Eye 2023; 37: 607-617
104481 A proposed theoretical framework for retinal biomarkers
Zhang B; Hill D
Alzheimer's & dementia (Amsterdam, Netherlands) 2022; 14: e12327
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Li X
Eye 2023; 37: 607-617
104481 A proposed theoretical framework for retinal biomarkers
Hill D
Alzheimer's & dementia (Amsterdam, Netherlands) 2022; 14: e12327
104861 Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Zhang B
Frontiers in public health 2022; 10: 944967
104481 A proposed theoretical framework for retinal biomarkers
Cordeiro MF
Alzheimer's & dementia (Amsterdam, Netherlands) 2022; 14: e12327
104861 Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Yang J
Frontiers in public health 2022; 10: 944967
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Li M
Eye 2023; 37: 607-617
104861 Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Yuan M
Frontiers in public health 2022; 10: 944967
104481 A proposed theoretical framework for retinal biomarkers
Small DS
Alzheimer's & dementia (Amsterdam, Netherlands) 2022; 14: e12327
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Wang Y; Dan H
Eye 2023; 37: 607-617
104861 Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Yang D
Frontiers in public health 2022; 10: 944967
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Zhou J
Eye 2023; 37: 607-617
104861 Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Wu J
Frontiers in public health 2022; 10: 944967
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Wei Y
Eye 2023; 37: 607-617
104861 Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Liu J; Zhao C
Frontiers in public health 2022; 10: 944967
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Ge K; Li P
Eye 2023; 37: 607-617
104861 Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Chen Y
Frontiers in public health 2022; 10: 944967
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Song Z
Eye 2023; 37: 607-617
104861 Validating automated eye disease screening AI algorithm in community and in-hospital scenarios
Xu Y
Frontiers in public health 2022; 10: 944967
